Post by Kyinno Biotechnology, Inc.

AI-powered affinity maturation is accelerating antibody optimization by identifying high-affinity variants with greater precision and efficiency. Kyinno Biotechnology, Inc. combines deep learning, structural modeling, and in silico antibody-antigen interaction analysis to guide VHH affinity maturation. By focusing on key CDR hotspot regions, our platform enables the design and screening of targeted mutant libraries, reducing experimental burden while maximizing the likelihood of identifying improved binders. This streamlined approach supports rapid affinity enhancement through high-throughput expression and screening, delivering antibody variants with significantly improved binding performance. In representative studies, optimized candidates achieved more than a ten-fold increase in affinity compared with the parental antibody. For more information, contact #Kyinno or visit our website: https://www.kyinno.com/ #AffinityMaturation #AntibodyEngineering #VHH #Nanobody #ArtificialIntelligence #MachineLearning #Biologics #AntibodyDiscovery #ProteinEngineering #DrugDevelopment #Biotech #Kyinno